Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Inozyme Pharma Inc (NQ: INZY ) 4.620 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jul 10, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 4.620 Bid (Size) 4.350 (3) Ask (Size) 5.100 (1) Prev. Close 4.620 Today's Range 4.620 - 4.620 52wk Range 2.689 - 7.795 Shares Outstanding 61,729,666 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Inozyme Pharma Announces FDA Fast Track Designation for INZ-701 in ABCC6 Deficiency July 02, 2024 Agency program will support and expedite clinical studies addressing severe unmet need in children with ABCC6 Deficiency From Inozyme Pharma Inc. Via GlobeNewswire Inozyme Pharma Announces Presentation and Sponsored Symposium at the 11th International Conference on Children’s Bone Health (ICCBH) June 21, 2024 Results from a radiographic study describing skeletal features of pediatric patients with ENPP1 Deficiency will be presented From Inozyme Pharma Inc. Via GlobeNewswire Performance YTD +6.70% +6.70% 1 Month -3.14% -3.14% 3 Month -11.83% -11.83% 6 Month +2.67% +2.67% 1 Year -21.43% -21.43% More News Read More Inozyme Pharma to Present at the Jefferies Global Healthcare Conference May 30, 2024 From Inozyme Pharma Inc. Via GlobeNewswire Inozyme Pharma: Q4 Earnings Insights March 12, 2024 Via Benzinga Inozyme Pharma to Present Recently Announced Data from Phase 1/2 Trials of INZ-701 in Adults with ENPP1 Deficiency and ABCC6 Deficiency (PXE) at Upcoming Medical Conferences May 23, 2024 From Inozyme Pharma Inc. Via GlobeNewswire Inozyme Pharma to Participate at the Bank of America Securities 2024 Health Care Conference May 08, 2024 From Inozyme Pharma Inc. Via GlobeNewswire INZY Stock Earnings: Inozyme Pharma Misses EPS for Q1 2024 May 07, 2024 Via InvestorPlace Inozyme Pharma Reports First Quarter 2024 Financial Results and Provides Business Highlights May 07, 2024 From Inozyme Pharma Inc. Via GlobeNewswire Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 03, 2024 From Inozyme Pharma Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Monday's After-Market Session April 29, 2024 Via Benzinga Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session April 09, 2024 Via Benzinga Inozyme Pharma Announces Positive Topline Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ABCC6 Deficiency (PXE) and ENPP1 Deficiency April 08, 2024 From Inozyme Pharma Inc. Via GlobeNewswire Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) April 05, 2024 From Inozyme Pharma Inc. Via GlobeNewswire Inozyme Pharma to Participate at the 23rd Annual Needham Virtual Healthcare Conference April 02, 2024 From Inozyme Pharma Inc. Via GlobeNewswire Top 5 Health Care Stocks That May Plunge In March March 28, 2024 Via Benzinga Inozyme Pharma to Report Topline Data from Ongoing Phase 1/2 Trials of INZ-701 in Adults with ABCC6 Deficiency and ENPP1 Deficiency on April 8, 2024 March 26, 2024 From Inozyme Pharma Inc. Via GlobeNewswire Inozyme Pharma Reports Full Year 2023 Financial Results and Provides Business Highlights March 12, 2024 From Inozyme Pharma Inc. Via GlobeNewswire Inozyme Pharma to Participate in the TD Cowen 44th Annual Health Care Conference February 26, 2024 From Inozyme Pharma Inc. Via GlobeNewswire Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) February 06, 2024 From Inozyme Pharma Inc. Via GlobeNewswire Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) December 05, 2023 From Inozyme Pharma Inc. Via GlobeNewswire Inozyme Pharma to Participate in Upcoming Investor Conferences November 09, 2023 From Inozyme Pharma Inc. Via GlobeNewswire Inozyme Pharma Reports Third Quarter 2023 Financial Results and Provides Business Highlights November 07, 2023 From Inozyme Pharma Inc. Via GlobeNewswire Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) November 03, 2023 From Inozyme Pharma Inc. Via GlobeNewswire Inozyme Pharma Announces Presentation at the American Society of Nephrology (ASN) Kidney Week 2023 October 26, 2023 From Inozyme Pharma Inc. Via GlobeNewswire Inozyme Pharma Highlights Inclusion of Generalized Arterial Calcification of Infancy (GACI) in Genomics England’s Generation Study of Rare Conditions October 10, 2023 From Inozyme Pharma Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
